BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

501 related articles for article (PubMed ID: 25629739)

  • 21. Less-tight versus tight control of hypertension in pregnancy.
    Magee LA; Singer J; von Dadelszen P;
    N Engl J Med; 2015 Jun; 372(24):2367-8. PubMed ID: 26061848
    [No Abstract]   [Full Text] [Related]  

  • 22. Long-Term Blood Pressure Control After Hypertensive Pregnancy Following Physician-Optimized Self-Management: The POP-HT Randomized Clinical Trial.
    Kitt J; Fox R; Frost A; Shanyinde M; Tucker K; Bateman PA; Suriano K; Kenworthy Y; McCourt A; Woodward W; Lapidaire W; Lacharie M; Santos M; Roman C; Mackillop L; Delles C; Thilaganathan B; Chappell LC; Lewandowski AJ; McManus RJ; Leeson P
    JAMA; 2023 Nov; 330(20):1991-1999. PubMed ID: 37950919
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of antihypertensive therapy in mild to moderate pregnancy-induced hypertension: a prospective randomized study comparing labetalol with alpha methyldopa.
    Molvi SN; Mir S; Rana VS; Jabeen F; Malik AR
    Arch Gynecol Obstet; 2012 Jun; 285(6):1553-62. PubMed ID: 22249781
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lowering diastolic blood pressure in non-proteinuric hypertension in pregnancy is not harmful to the fetus and is associated with reduced frequency of severe maternal hypertension.
    August P
    Evid Based Med; 2015 Aug; 20(4):141. PubMed ID: 26141178
    [No Abstract]   [Full Text] [Related]  

  • 25. Do maternal- or pregnancy-associated disease states affect blood pressure in the early neonatal period?
    Kent AL; Shadbolt B; Hu E; Meskell S; Falk MC; Dahlstrom JE
    Aust N Z J Obstet Gynaecol; 2009 Aug; 49(4):364-70. PubMed ID: 19694689
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Report of the Canadian Hypertension Society Consensus Conference: 3. Pharmacologic treatment of hypertensive disorders in pregnancy.
    Rey E; LeLorier J; Burgess E; Lange IR; Leduc L
    CMAJ; 1997 Nov; 157(9):1245-54. PubMed ID: 9361646
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Can adverse maternal and perinatal outcomes be predicted when blood pressure becomes elevated? Secondary analyses from the CHIPS (Control of Hypertension In Pregnancy Study) randomized controlled trial.
    Magee LA; von Dadelszen P; Singer J; Lee T; Rey E; Ross S; Asztalos E; Murphy KE; Menzies J; Sanchez J; Gafni A; Gruslin A; Helewa M; Hutton E; Lee SK; Logan AG; Ganzevoort W; Welch R; Thornton JG; Moutquin JM
    Acta Obstet Gynecol Scand; 2016 Jul; 95(7):763-76. PubMed ID: 26915709
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New Evidence in the Management of Chronic Hypertension in Pregnancy.
    Podymow T; August P
    Semin Nephrol; 2017 Jul; 37(4):398-403. PubMed ID: 28711079
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of L-arginine on blood pressure in pregnancy-induced hypertension: a randomized placebo-controlled trial.
    Neri I; Jasonni VM; Gori GF; Blasi I; Facchinetti F
    J Matern Fetal Neonatal Med; 2006 May; 19(5):277-81. PubMed ID: 16753767
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Factors associated with postpartum readmission for hypertensive disorders of pregnancy.
    Bruce KH; Anderson M; Stark JD
    Am J Obstet Gynecol MFM; 2021 Sep; 3(5):100397. PubMed ID: 33991709
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antepartum dalteparin versus no antepartum dalteparin for the prevention of pregnancy complications in pregnant women with thrombophilia (TIPPS): a multinational open-label randomised trial.
    Rodger MA; Hague WM; Kingdom J; Kahn SR; Karovitch A; Sermer M; Clement AM; Coat S; Chan WS; Said J; Rey E; Robinson S; Khurana R; Demers C; Kovacs MJ; Solymoss S; Hinshaw K; Dwyer J; Smith G; McDonald S; Newstead-Angel J; McLeod A; Khandelwal M; Silver RM; Le Gal G; Greer IA; Keely E; Rosene-Montella K; Walker M; Wells PS;
    Lancet; 2014 Nov; 384(9955):1673-83. PubMed ID: 25066248
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pregnancy outcomes in a prospective matched control study of pregnancy and renal disease.
    Holley JL; Bernardini J; Quadri KH; Greenberg A; Laifer SA
    Clin Nephrol; 1996 Feb; 45(2):77-82. PubMed ID: 8846534
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The impact of maternal obesity on the incidence of adverse pregnancy outcomes in high-risk term pregnancies.
    Joy S; Istwan N; Rhea D; Desch C; Stanziano G
    Am J Perinatol; 2009 May; 26(5):345-9. PubMed ID: 19067282
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Maternal and newborn outcomes among women with schizophrenia: a retrospective population-based cohort study.
    Vigod SN; Kurdyak PA; Dennis CL; Gruneir A; Newman A; Seeman MV; Rochon PA; Anderson GM; Grigoriadis S; Ray JG
    BJOG; 2014 Apr; 121(5):566-74. PubMed ID: 24443970
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tight vs liberal control of mild postpartum hypertension: a randomized controlled trial.
    Aderibigbe OA; Hackney DN; Ranzini AC; Lappen JR
    Am J Obstet Gynecol MFM; 2023 Feb; 5(2):100818. PubMed ID: 36402355
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Medical treatment of early-onset mild gestational hypertension reduces total peripheral vascular resistance and influences maternal and fetal complications.
    Vasapollo B; Novelli GP; Gagliardi G; Tiralongo GM; Pisani I; Manfellotto D; Giannini L; Valensise H
    Ultrasound Obstet Gynecol; 2012 Sep; 40(3):325-31. PubMed ID: 22259197
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypertension: Tight control of hypertension is safe in pregnant women.
    Huynh K
    Nat Rev Cardiol; 2015 Apr; 12(4):196. PubMed ID: 25687776
    [No Abstract]   [Full Text] [Related]  

  • 38. [Hypertensive disorders in pregnancy].
    Dürig P; Ferrier C; Schneider H
    Ther Umsch; 1999 Oct; 56(10):561-71. PubMed ID: 10549228
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of fixed-dose combinations of telmisartan/hydrochlorothiazide 40/12.5 mg and 80/12.5 mg and a fixed-dose combination of losartan/hydrochlorothiazide 50/12.5 mg in mild to moderate essential hypertension: pooled analysis of two multicenter, prospective, randomized, open-label, blinded-end point (PROBE) trials.
    Lacourcière Y; Neutel JM; Schumacher H
    Clin Ther; 2005 Nov; 27(11):1795-805. PubMed ID: 16368450
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Obstetric outcomes in pregnant women with diabetes versus hypertensive disorders versus both.
    Potti S; Jain NJ; Mastrogiannis DS; Dandolu V
    J Matern Fetal Neonatal Med; 2012 Apr; 25(4):385-8. PubMed ID: 21627547
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.